Related Experiment Video
Updated: May 8, 2026
09:30
Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Insurance for the compounding pharmacy business, part 2: what, when, and where
1Renaud, Cook, Drury, Mesaros, PA, Phoenix, Arizona.
International Journal of Pharmaceutical Compounding
|August 24, 2013
Summary
Pharmacy practice has evolved, increasing legal risks for pharmacists. Understanding professional liability insurance is crucial for adequate coverage in today's complex healthcare environment.
Area of Science:
- Pharmacy Practice
- Healthcare Law
- Risk Management
Background:
- Historically, pharmacy practice focused on dispensing accuracy, with minimal legal liability for pharmacists before the 1980s.
- Medication errors, though serious, were infrequent due to lower prescription volumes, resulting in fewer claims.
- Contemporary pharmacy practice involves complex duties, including prospective drug review and patient counseling, leading to increased litigation risks.
Purpose of the Study:
- To highlight the evolution of pharmacy practice and its impact on legal liabilities.
- To emphasize the importance of understanding professional liability insurance for pharmacists.
- To guide pharmacy owners and pharmacists in selecting adequate insurance policies.
Main Methods:
- Review of historical pharmacy practices and legal precedents.
- Analysis of current trends in community pharmacy prescription volume and associated claims.
- Examination of changes in pharmacists' professional duties and relevant legislation.
Main Results:
- Significant increase in prescription volume (over 3 billion annually) correlates with a rise in claims against pharmacists.
- Existing professional liability insurance policies may not adequately cover contemporary pharmacy practice risks.
- Divergence in practice, expanded duties, and current laws necessitate careful policy review.
Conclusions:
- Pharmacists must proactively understand their professional liability insurance to ensure sufficient coverage.
- Informed insurance choices are essential for mitigating risks in modern pharmacy practice.
- Adapting insurance coverage to evolving legal and professional landscapes is critical for pharmacy owners and practitioners.
More Related Videos
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
01:20Compartment Models: Two-Compartment Model
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...